Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur J Pediatr ; 182(1): 461-466, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36282324

RESUMO

Scarce evidence exists about the best treatment for multi-system inflammatory syndrome (MIS-C). We analyzed the effects of steroids, intravenous immunoglobulin (IVIG), and their combination on the probability of discharge over time, the probability of switching to second-line treatment over time, and the persistence of fever 2 days after treatment. We did a retrospective study to investigate the effect of different treatments on children with MIS-C from 1 March 2020 to 1 June 2021. We estimated the time-to-event probability using a Cox model weighted by propensity score to balance the baseline characteristics. Thirty of 132 (22.7%) patients were initially treated with steroids alone, 29/132 (21.9%) with IVIG alone, and 73/132 (55%) with IVIG plus steroids. The probability of early discharge was higher with IVIG than with IVIG plus steroids (hazard ratio [HR] 1.65, 95% CI 1.11-2.45, p = 0.013), but with a higher probability of needing second-line therapy compared to IVIG plus steroids (HR 3.05, 95% CI 1.12-8.25, p = 0.028). Patients on IVIG had a higher likelihood of persistent fever than patients on steroids (odds ratio [OR] 4.23, 95% CI 1.43-13.5, p = 0.011) or on IVIG plus steroids (OR 4.4, 95% CI 2.05-9.82, p < 0.001). No differences were found for this endpoint between steroids or steroids plus IVIG.    Conclusions: The benefits of each approach may vary depending on the outcome assessed. IVIG seemed to increase the probability of earlier discharge over time but also of needing second-line treatment over time. Steroids seemed to reduce persistent fever, and combination therapy reduced the need for escalating treatment. What is Known: • Steroids plus intravenous immunoglobulin, compared with intravenous immunoglobulin alone for multi-system inflammatory syndrome (MIS-C) might reduce the need for hemodynamic support and the duration of fever, but the certainty of the evidence is low. What is New: • Intravenous immunoglobulin, steroids, and their combination for MIS-C may have different outcomes. • In this study, intravenous immunoglobulin increased the probability of discharge over time, steroids reduced persistent fever, while combination therapy reduced the need for second-line treatments.


Assuntos
Imunoglobulinas Intravenosas , Alta do Paciente , Humanos , Criança , Imunoglobulinas Intravenosas/efeitos adversos , Estudos Retrospectivos , Febre/tratamento farmacológico , Febre/etiologia , Esteroides/uso terapêutico
2.
Arch Sex Behav ; 47(3): 737-745, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29392485

RESUMO

This cross-sectional study examined whether university students from the U.S. (n = 392) and Spain (n = 200) considered the viewing of sexually explicit material (SEM) to be tantamount to committing infidelity. Participants' ages ranged from 18 to 36 (U.S. sample) and 18 to 35 (Spain sample), respectively. At both universities, the study was made available to students via a computer program that allows recruitment and completion of the questionnaires online. It was found that the majority of U.S. and Spanish participants (73 and 77%, respectively) indicated that they did not consider viewing SEM as an act of infidelity. Also, overall, U.S. participants, those who were not currently in a relationship, and those who do not view SEM, were significantly more likely to believe that viewing SEM constituted infidelity compared to Spanish participants, those currently in a relationship, and those who view SEM. Finally, it was found that among U.S. and Spanish participants, intolerance of infidelity in general, negative attitudes toward SEM, and the proclivity for jealousy significantly correlated with believing that viewing SEM was tantamount to infidelity. For U.S. participants only, religiosity and (low) self-esteem also correlated with the belief that viewing SEM was infidelity. Implications of the findings are discussed.


Assuntos
Literatura Erótica/psicologia , Comportamento Sexual/psicologia , Parceiros Sexuais/psicologia , Adolescente , Adulto , Estudos Transversais , Humanos , Ciúme , Espanha/epidemiologia , Estudantes/psicologia , Estudantes/estatística & dados numéricos , Inquéritos e Questionários , Estados Unidos/epidemiologia , Adulto Jovem
3.
BMC Complement Altern Med ; 14: 311, 2014 Aug 23.
Artigo em Inglês | MEDLINE | ID: mdl-25151398

RESUMO

BACKGROUND: The aging process involves a decline in immune functioning that renders elderly people more vulnerable to disease. In residential programs for the aged, it is vital to diminish their risk of disease, promote their independence, and augment their psychological well-being and quality of life. METHODS: We performed a randomized controlled study, evaluating the ability of a relaxation technique based on Benson's relaxation response to enhance psychological well-being and modulate the immune parameters of elderly people living in a geriatric residence when compared to a waitlist control group. The study included a 2-week intervention period and a 3-month follow-up period. The main outcome variables were psychological well-being and quality of life, biomedical variables, immune changes from the pre-treatment to post-treatment and follow-up periods. RESULTS: Our findings reveal significant differences between the experimental and control groups in CD19, CD71, CD97, CD134, and CD137 lymphocyte subpopulations at the end of treatment. Furthermore, there was a decrease in negative affect, psychological discomfort, and symptom perception in the treatment group, which increased participants' quality of life scores at the three-month follow-up. CONCLUSIONS: This study represents a first approach to the application of a passive relaxation technique in residential programs for the elderly. The method appears to be effective in enhancing psychological well-being and modulating immune activity in a group of elderly people. This relaxation technique could be considered an option for achieving health benefits with a low cost for residential programs, but further studies using this technique in larger samples of older people are needed to confirm the trends observed in the present study. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number Register ISRCTN85410212.


Assuntos
Envelhecimento/imunologia , Envelhecimento/psicologia , Terapia de Relaxamento , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Casas de Saúde , Qualidade de Vida , Relaxamento , Projetos de Pesquisa , Linfócitos T/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA